Global and Local Companies Support Scientific Progress

**Global and Local Companies Support Scientific Progress at the Second Medical Forum for Duchenne Muscular Dystrophy and Physical Therapy**

The Second Medical Forum, organized by Al Hadi Center for Myopathies and Neuropathies on the occasion of World Duchenne Muscular Dystrophy Day and Physical Therapy, witnessed active and prominent participation from a number of leading global and local companies in the medical field.

The event saw participation from:

- MDF Company for Medical Devices

- Al Jawhara Al Memar Company for Medical Devices

- Strand Company for Genetic Analysis

- PharmaLine / Al Ma'moura Pharmaceutical Office

Their qualitative contributions formed a genuine addition to the trajectory of scientific progress in diagnosing and treating neuromuscular diseases. They contributed by showcasing the latest medical technologies, diagnostic and therapeutic devices, alongside opening avenues for cooperation and knowledge exchange with doctors and specialists.

This constructive presence reflects the importance of partnerships between the medical sector and supporting companies. It confirms that success in confronting rare diseases requires the unification of science, expertise, and institutional support to foster hope for thousands of patients and their families.